Zolbetuximab | m-entrepreneurship.com

Product Name :
Zolbetuximab

Search keywords :
Zolbetuximab

drugId :
null

Target Vo:
Claudin-18 splice variant 2

Target Vo Short Name :
Claudin 18.2

Moa_Name:
Antibody-dependent cell-mediated cytotoxicity (ADCC) effects

First Approval Country :
Japan

First Approval Date Filter:
2024

Origin Company_Name :
Ganymed

Active Company_Name :
Astellas (China) Investment Co Ltd

Active Indication_Name:
Stomach Neoplasms

In Active Indication_Name:
Lymphangioma, Cystic

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
NDA/BLA

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
RAB7 Antibody
RAGE Antibody
CD38 Antibody: CD38 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to CD38. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts